GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nxera Pharma Co 4565.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,704

+7.37%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥29.61bn

FY2016FY2025

Net income

−¥12.53bn

FY2016FY2025

Free cash flow

−¥3.12bn

FY2016FY2025

Shareholders' equity

¥61.00bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue¥29.61bn¥28.84bn¥12.77bn¥15.57bn¥17.71bn¥8.84bn¥9.73bn¥3.83bn¥6.96bn¥18.90bn
Gross profit¥21.42bn¥18.13bn¥7.87bn¥13.80bn¥15.98bn¥7.17bn¥7.81bn¥2.01bn¥6.96bn¥17.98bn
Research and development¥14.47bn¥11.82bn¥10.07bn¥7.45bn¥5.93bn¥3.79bn¥4.29bn¥7.18bn¥4.93bn¥3.12bn
Operating income−¥8.27bn−¥5.36bn−¥9.06bn¥2.81bn¥6.91bn¥853.0m¥969.0m−¥7.40bn−¥2.57bn¥12.13bn
Net income−¥12.53bn−¥4.84bn−¥7.19bn¥382.0m¥1.02bn¥1.48bn¥1.43bn−¥7.95bn−¥2.65bn¥9.80bn
Diluted earnings per share-138.72-53.81-80.424.6612.3118.4818.58-104.16-39.12144.38

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets¥134.79bn¥151.50bn¥157.20bn¥100.22bn¥98.42bn¥77.18bn¥56.68bn¥58.99bn¥69.49bn¥48.09bn
Cash and short-term investments¥20.36bn¥36.20bn¥49.06bn¥66.56bn¥60.09bn¥40.01bn¥15.38bn¥18.76bn¥28.28bn¥13.90bn
Total liabilities¥73.79bn¥82.98bn¥90.39bn¥42.29bn¥40.95bn¥24.80bn¥11.60bn¥17.41bn¥20.60bn¥19.24bn
Debt¥57.38bn¥67.90bn¥73.97bn¥29.73bn¥29.27bn¥16.62bn¥3.37bn¥6.96bn¥9.90bn¥6.90bn
Shareholders' equity¥61.00bn¥68.52bn¥66.81bn¥57.94bn¥57.47bn¥52.38bn¥45.08bn¥41.58bn¥48.88bn¥28.84bn
Shares outstanding90m90m89m82m83m80m77m76m68m68m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−¥2.67bn−¥7.72bn−¥5.27bn¥9.95bn¥7.09bn¥4.67bn¥3.44bn−¥4.00bn−¥2.17bn¥12.86bn
Capital spending−¥448.0m−¥526.0m−¥804.0m−¥303.0m−¥193.0m−¥92.0m−¥271.0m−¥1.81bn−¥880.0m−¥332.0m
Free cash flow−¥3.12bn−¥8.24bn−¥6.08bn¥9.65bn¥6.90bn¥4.58bn¥3.17bn−¥5.80bn−¥3.05bn¥12.52bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥7.65bn¥11.26bn¥7.77bn¥6.75bn¥8.45bn¥6.64bn¥6.85bn¥9.26bn
Gross profit¥5.49bn¥10.14bn¥5.71bn¥4.08bn¥6.59bn¥5.03bn¥4.72bn¥6.27bn
Operating income−¥864.0m¥3.54bn−¥1.37bn−¥3.49bn−¥939.0m−¥2.48bn−¥2.87bn¥541.0m
Net income−¥202.0m¥1.79bn−¥7.72bn−¥1.67bn−¥2.38bn−¥760.0m−¥1.33bn¥1.20bn
Diluted earnings per share-2.2119.62-85.48-18.51-26.32-8.41-14.8513.35
Cash from operations¥5.63bn−¥1.65bn−¥125.0m−¥2.98bn−¥180.0m¥613.0m−¥10.97bn¥1.74bn
Capital spending−¥52.0m−¥304.0m−¥147.0m−¥102.0m−¥90.0m−¥109.0m−¥153.0m−¥271.0m
Free cash flow¥5.58bn−¥1.96bn−¥272.0m−¥3.08bn−¥270.0m¥504.0m−¥11.12bn¥1.47bn
Total assets¥132.38bn¥133.34bn¥134.79bn¥144.18bn¥144.69bn¥145.69bn¥151.50bn¥152.34bn
Cash and short-term investments¥17.75bn¥11.60bn¥20.36bn¥28.46bn¥33.00bn¥34.47bn¥36.20bn¥48.87bn
Debt¥51.92bn¥6.70bn¥53.87bn¥6.67bn¥61.66bn¥6.68bn¥6.69bn¥6.66bn
Shareholders' equity¥64.80bn¥63.69bn¥61.00bn¥65.66bn¥65.86bn¥67.07bn¥68.52bn¥67.76bn

Financial ratios

Data as of 12 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin72.3%62.9%61.6%88.6%90.2%81.1%
Operating margin-27.9%-18.6%-71.0%18.1%39.0%9.6%
Net margin-42.3%-16.8%-56.3%2.5%5.7%16.7%
Return on equity-20.5%-7.1%-10.8%0.7%1.8%2.8%
Return on assets-9.3%-3.2%-4.6%0.4%1.0%1.9%
Free cash flow yield-2.4%-7.1%-4.9%10.1%7.1%4.8%
Revenue growth2.7%125.9%-18.0%-12.1%100.3%-9.1%
Earnings growth159.0%-32.7%-1983.0%-62.4%-31.2%3.3%
Current ratio2.54x3.70x3.79x17.09x8.73x14.08x
Debt to equity0.88x0.94x1.05x0.49x0.48x0.29x
Equity ratio45.3%45.2%42.5%57.8%58.4%67.9%
Interest coverage-1.11x-6.90x-11.28x3.93x13.08x4.00x
R&D as a share of sales48.8%41.0%78.9%47.9%33.5%42.9%
Buybacks as a share of market value-0.5%-0.5%-9.2%0.8%-3.2%-3.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.9%27.3%13.8%
Net income——24.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin67.7%70.5%74.4%78.5%
Operating margin-23.3%-22.9%-10.7%-5.0%
Net margin-29.7%-27.9%-19.1%-14.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-6.0-19.5-17.7458.5154.697.4116.8-7.7-69.923.3
Price to sales2.53.310.011.38.916.317.215.926.712.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Mar 2015.

FY2015
Paid in the year2.50
  • 4-for-1 split · 27 Jun 2018
  • 100-for-1 split · 27 Mar 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.